Genmab — September 2020

[Solsen]

Jeg ved det ikke. Husker kun han sagde, at deres PD-L1 x 4-1BB could break open the whole solid cancer market

[Sukkeralf]

Vi behøver heller ikke mere end det, hvis PD-L1/4-1BB rydder bordet ved SITC - så er vores lykke gjort

[E_L]

I think he means with JNJ, because in total, with everyone, there are more. EXcluding HexaCD38 i would count 6 JNJ

[E_L]

Teclistamab
, Talquetamab
, Amivantamab, CD33 x CD3
, CD123 x CD3, PSMAxCD3

[Sukkeralf]

Partner owned BsAbs - 6 Janssen and 1 Novo in the clinic

[E_L]

I think the INDs for this year were Talquetamab (CD3 GPRC5D
)

and HexCD38?

[Sukkeralf]

CD3/5T4 and HexaCD38

[E_L]

correct. i knew there was a 5 in there

[E_L]

you made me listen to the presentation again , and i am impressed again
lol

[E_L]

imagine the difference for patients if they could do without chemo

[Solsen]

Yes its a landmark in treating cancer pts.

[Mogan]

Ligner at markedet også er ved at indse potentialet - de har nok læst PI

[Helge_LarsenPI-redaktør]

[Budweis]

Jeg fik hørt firechatten med Winkel i går. Wow! For første gang stod det mig klart hvordan det er visionen kommer til at folde sig ud. By 2025, our own product has transformed cancer treatment and we have a pipeline of knock-your-socks-off antibodies. Virkelig værd at lytte til!

[Solsen]

[Sukkeralf]

Det ender vel med at CMD den 13/11-2020 bliver større end juleaften

[Solsen]

Det kunne være der skulle dug på bordet diskes op med “rigelig smør“ og rødvin.

[Sukkeralf]

og så en veganer bøf................ååhhhh nej tak

[Mogan]

Kommer næsten til at passe med Mortens-aften den 10. /11, men bedre at lave en ny tradition en GEN-aften. Måske på dagen for Genmabs Stiftelsesdag

[Solsen]

Øget konkurrence i cervical https://finance.yahoo.com/news/agenus-presents-results-two-large-070000762.html